<DOC>
	<DOCNO>NCT00628394</DOCNO>
	<brief_summary>This research do people schizophrenia often problem think include learning , remember , pay attention , problem solving . During study , test cognitive remediation ( computer game make improve thinking ) , use along drug call atomoxetine , may help problem think well symptom schizophrenia .</brief_summary>
	<brief_title>Treating Cognition Schizophrenia With Atomoxetine Cognitive Remediation</brief_title>
	<detailed_description>Persons schizophrenia stable residual antipsychotic- treat clinical condition least 8 week recruit several public mental health treatment setting UTSW Schizophrenia Research Clinic . Each volunteer receive information protocol risk benefit . If give informed consent full opportunity learn detail study , allow proceed . All recruit treat optimal dose 2nd generation antipsychotic drug ( APD-2 ) clinically stable respect psychotic symptom least 6 week prior randomization , stable dose medication least 2 week . All eligible volunteer receive routine medical assessment psychiatric diagnostic work-up include SCID consensus diagnosis two experience clinician base available data , prior randomization . Just prior randomization , follow set assessment perform : ( 1 ) Medical : Physical Examination , Clinical Chemistries , EKG , urinalysis , weight , vital sign ; ( 2 ) Symptomatic : general psychiatric symptom assessment , include score PANSS , Psychosis Change Scale , CGI ; ( 3 ) Cognitive : standard neuropsychometric test battery surrogate psychosocial test ; assessment battery repeat end 12-week treatment period , repeat end three month follow-up period ( 6 month study start ) . Clinical symptom scale , weight , vital sign repeat week 4 , 8 , 12 , 16 , 24 study . The schizophrenia volunteer randomize four treatment group : ( 1 ) atomoxetine plus cognitive remediation ; ( 2 ) atomoxetine plus remediation control ; ( 3 ) placebo plus cognitive remediation ; ( 4 ) placebo plus remediation control . Atomoxetine match placebo administer dose 40mg bid ( 80mg/day ) placebo equivalent . The remediation sequence last 60 minute administer three time weekly ; remediation control administer schedule duration . Because volunteer attend clinic regularly , opportunity track progress , monitor medication adherence , optimize study participation . Then , volunteer follow take blind study medication , without remediation/control session , next 3 month . Psychiatric rating scale complete follow time , relative blind randomization : baseline , 1 , 2 , 3 , 4 , 5 , 6 month , whereas neuropsychological battery complete baseline 3 6 month .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>DSMIV diagnosis schizophrenia schizoaffective disorder . Males female . Ages 1860 year old . All race ethnicity . Diagnosis organic brain disease . Diagnosis DSMIV alcohol substance abuse within last month DSMIV alcohol substance dependence within last 3 month . Meet criteria primary negative symptom , establish clinical judgment . Current past history clozapine treatment antipsychotic nonresponse . Patients hospitalize psychiatric hospital within previous 30 day . Patients unstable medical condition , determine Investigator Colorblindness Concurrent treatment electroconvulsive therapy psychotherapy . Pregnant woman . Must able read , speak , understand English . We resource necessary properly study nonEnglish speaking patient study . The computer software use cognitive remediation clinical assessment available English . The need provide resource foreign language would prohibitive successful completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Cognition</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>Atomoxetine</keyword>
	<keyword>Strattera</keyword>
	<keyword>cognitive remediation</keyword>
</DOC>